| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |